The Trader 

Market Outlook: £46 billion boom

The Trader

The board of Irish pharmaceuticals firm Shire unanimously recommended shareholders accept the offer on the table from Japanese drug maker Takeda.  This follows an increase in the cash component of the bid and a price 59.6 per cent higher than it was when the firm first expressed an interest.   

To continue reading, register today

to enjoy limited access to the following:

  • Daily trading news
  • Funds coverage
  • Features on big investment themes
  • Comprehensive companies coverage
  • Economic analysis
Register
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now